ConforMIS, which sells customized joint replacement implants, filed on Friday with the SEC to raise up to $173 million in an initial public offering.
The Bedford, MA-based company, which was founded in 2004 and booked $52 million in sales for the 12 months ended March 31, 2015, plans to list on the NASDAQ under the symbol CFMS. ConforMIS initially filed confidentially on 3/20/2015. J.P. Morgan and Deutsche Bank are the joint bookrunners on the deal. No pricing terms were disclosed.
